PMG
CSFL

ProVise Management Group’s CenterState Bank Corporation Common Stock CSFL Stock Holding History

ProVise Management Group’s Portfolio CSFL Stock Details CSFL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-25,646
Closed -$442K – 293
2020
Q1 		$442K Buy
25,646
+1,424
+6% +$30.9K 0.07% 185
2019
Q4 		$605K Buy
24,222
+9
+0% +$225 0.07% 186
2019
Q3 		$581K Buy
24,213
+9
+0% +$210 0.08% 184
2019
Q2 		$557K Buy
24,204
+9,658
+66% +$227K 0.07% 195
2019
Q1 		$346K Hold
14,546
– – 0.05% 224
2018
Q4 		$306K Hold
14,546
– – 0.05% 231
2018
Q3 		$408K Buy
14,546
+178
+1% +$5.32K 0.05% 233
2018
Q2 		$428 Hold
14,368
– – 0.03% 232
2018
Q1 		$381K Buy
+14,368
New +$385K 0.06% 223

Other funds holding CSFL

RFC
Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

ProVise Management Group's CSFL Position: Q2 2020 in Review

ProVise Management Group sold out of CenterState Bank Corporation Common Stock (CSFL) in Q2 2020, closing a stake of 25,646 shares — an estimated $442K sold.

ProVise Management Group first reported a position in CSFL in Q1 2018 and held it in 9 quarters. The position peaked at $605K in Q4 2019. 2 funds tracked by Wall St. Rank hold CSFL as of Q2 2020.

  • ProVise Management Group reported no remaining CenterState Bank Corporation Common Stock position as of Q2 2020 after selling out during the quarter.
  • ProVise Management Group sold 25,646 CenterState Bank Corporation Common Stock shares in Q2 2020, an estimated $442K.
  • ProVise Management Group first reported a position in CenterState Bank Corporation Common Stock in Q1 2018 and held it in 9 quarters.
  • ProVise Management Group's CenterState Bank Corporation Common Stock position peaked at $605K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held CenterState Bank Corporation Common Stock as of Q2 2020.

Based on ProVise Management Group's 13F filing for Q2 2020, filed 7 Aug 2020.